Predictive commercial strategy scoring, benchmarks, and diagnostics for PE investors and operators — fast enough for diligence, rigorous enough for the board.
Based on 800+ B2B companies evaluated.
Sources: A&M 2025 · Simon-Kucher 2025 · EY PE Survey 2025 · Gong 2025
Remidi measures the commercial strategy elements that drive these gaps, so operators can see them, size them, and fix them.
Independent scoring, same framework, every company. See what's working without relying on management to tell you.
Commercial strategy problems are leading indicators. Scores surface them months before the revenue miss.
Scored, ranked, benchmarked. When data shows bottom-quartile pricing, the debate ends and work starts.
Three decades building commercial measurement businesses — including a $200M+ global analytics platform at Nielsen used across 27 countries. We know how to build data systems right. As a 5x PE-backed SaaS CMO and 3x Operating Partner, we know how to make that data actionable. Meet the founder →
Consistent, predictive, benchmarkable data from sourcing through exit.
Score every company. Benchmark against peers. Prioritize what to fix. Track whether it's working.
0-100 across four dimensions and 28 sub-scores. One number that tells the whole commercial story.
Compare against competitors, your fund, and our 800+ company database.
Prioritized actions ranked by revenue impact. Specific, measurable, with dollar estimates attached.
Quarterly re-scoring shows what's improving, what's not, and where to refocus.
Findings and insights from our 800+ company database, delivered every two weeks.